In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Wyeth announces strategic collaboration with Trubion Pharmaceuticals
Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicine
Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines
Curis announces expansion of relationship with Centocor Research & Development, Inc
Wyeth and Solvay Pharmaceuticals to Co-Develop Four Product Candidates and Co-Promote Effexor XR
Tanox, Inc. announces cross-licensing agreement in osteoporosis market with Wyeth Pharmaceuticals
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
